Maviret funding welcomed but GPs still worried about cost of prescribing

+News
In print

Maviret funding welcomed but GPs still worried about cost of prescribing

Drug addict
Among the thousands of people in New Zealand infected with hepatitis C are those who injected drugs, sometimes decades ago
They’re relying on the goodwill of GPs to just do it. It’s the recurring theme of increasing workload without remuneration The funding of pan-gen, Alex Lampen-Smith, Hepatitis Foundation NZ clinical director Alex Lampen-Smith says Maviret will make a huge difference